Elspar and Infarction - a phase IV clinical study of FDA data

Summary:

Infarction is reported as a side effect among people who take Elspar (asparaginase), especially for people who are male, 2-9 old, also take Prednisone, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Infarction when taking Elspar. It is created by eHealthMe based on reports of 2,053 people who have side effects when taking Elspar from the FDA, and is updated regularly.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users. Check the latest studies of Elspar.

What is Infarction?

Infarction (obstruction of the blood supply to an organ or region of tissue) is found to be associated with 481 drugs and 607 conditions by eHealthMe. Check the latest studies of Infarction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

2,053 people reported to have side effects when taking Elspar.
Among them, 12 people (0.58%) have Infarction.

Among these 12 people:

What is the gender of people who have Infarction when taking Elspar? *

female: 40 %
male: 60 %

What is the age of people who have Infarction when taking Elspar? *

What are other drugs people take besides Elspar? *

What are other side effects people have besides Infarction? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 58.33%
Fever: 2 people, 16.67%
Bladder Dilatation: 2 people, 16.67%
Blood Bilirubin Increased: 2 people, 16.67%
Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid): 2 people, 16.67%
White Blood Cell Count Decreased: 1 person, 8.33%
Haematocrit Decreased: 1 person, 8.33%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 8.33%
Fibrin Degradation Products Increased: 1 person, 8.33%
Fatty Liver: 1 person, 8.33%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 8 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Elspar and have Infarction?

- Check whether Infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elspar:

Elspar (2,057 reports)

Infarction treatments and more:

Infarction (9,074 reports)

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infarction:

Infarction (481 drugs)

Browse all the conditions that are associated with Infarction:

Infarction (607 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asparaginase (the active ingredients of Elspar) and Elspar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.